Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Improving transitions and outcomes for heart failure patients receiving home health care

Official title: Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF): A Type 1 Hybrid Effectiveness- Implementation Trial

Run by Weill Medical College of Cornell University · NCT06118983 · Data updated 2026-11-12

This study is testing a new program to help heart failure patients move from the hospital to home health care more smoothly and see if it can reduce the chances of them going back to the hospital within 30 days.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1094 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Locations2 sites (New York, New York and 1 other locations)
StatusRecruiting
StartedJuly 28, 2026
Main results expectedJuly 1, 2027
Study endsJuly 1, 2028
Registry record updatedAugust 21, 2026
Trial IDNCT06118983 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults hospitalized for heart failure who will transition to home health care services.

Probably not a fit

Patients who are discharged home without home health care or to other facilities like rehabilitation centers or hospice may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the transition of heart failure patients from hospitals to home health care services through an intervention called I-TRANSFER-HF. The intervention includes early home health nurse visits and timely outpatient medical appointments to reduce hospital readmissions within 30 days. Researchers will compare outcomes before and after implementing I-TRANSFER-HF across various hospital-home health agency pairs, utilizing Medicare claims data and qualitative interviews to assess the intervention's effectiveness and real-world implementation challenges.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce hospital readmissions and improve the overall quality of life for heart failure patients transitioning to home care.

How similar studies have gone: Other studies have shown promise in improving hospital-to-home transitions for heart failure patients, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Aim 1, Inclusion Criteria:

* Adults hospitalized for HF who transition from participating hospitals to their partner HHC agency during the study period.

Aim 1, Exclusion Criteria:

* Patients hospitalized for HF and discharged: home without HHC, or to an inpatient rehabilitation facility, skilled nursing facility, or hospice; patients with end stage renal disease on dialysis and those with left ventricular devices.

Aim 2, Inclusion Criteria:

\- Healthcare professional involved in the transition of heart failure patients from the acute care setting (hospital) to HHC (home health care) agencies, and the implementation of the I-TRANSFER-HF at one of the four participating hospital-HHC dyads.

Aim 2, Exclusion Criteria:

\- Healthcare professional not involved in the transition of heart failure patients from the acute care setting (hospital) to HHC (home health care) agencies, and the implementation of the I-TRANSFER-HF at one of the four participating hospital-HHC dyads.

Where it's running

  • VNS Health Partners in Care
    New York, New York, United States
    Recruiting
  • Weill Cornell Medicine
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Madeline R Sterling, MD, MPH, MS — Weill Medical College of Cornell University
  • Study coordinator: Madeline R Sterling, MD, MPH, MS
  • Email: mrs9012@med.cornell.edu
  • Phone: 6469625029

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.